Pasireotide Injection and Iloperidone: Interaction Details
- Iloperidone
- Fanapt
- Pasireotide Injection
- SigniforSignifor LAR
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Pasireotide Injection and Iloperidone interaction:
Pasireotide Injection
- Signifor
- Signifor LAR
What Happens When You Take Pasireotide Injection With Iloperidone
What can happen when they are taken together (rated Major)
Increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
QT-interval prolongation is a recognized effect of pasireotide. Two studies found that this prolongation developed with pasireotide at therapeutic doses as well as at supratherapeutic doses.
When pasireotide is given together with other agents that lengthen the , antiarrhythmic drugs among them, their effects on the QT interval may be . If pasireotide is coadministered with other QT-prolonging drugs, ECGs are recommended at baseline and again 21 days after treatment is started.1
The Pasireotide Injection and Iloperidone Interaction, Explained
Both iloperidone (an used for schizophrenia) and pasireotide (an injection used for Cushing's disease or acromegaly) can affect the heart's electrical rhythm. Each can lengthen a part of the heartbeat called the . Taking them together may add up that effect and raise the chance of an abnormal heart rhythm. This concern is based on how the drugs work rather than on reports of problems in people taking both.
Keep taking both as prescribed. Your care team can check your heart tracing () and may monitor you more closely. Tell them right away about fainting, dizziness, or a racing or fluttering heartbeat.
(). Pasireotide prolonged QT at therapeutic and supratherapeutic doses in 2 studies. Iloperidone is also associated with dose-related QTc prolongation. may have additive effects on the . Evidence is theoretical (no direct interaction data); onset unspecified; severity rated major.
- Obtain a baseline and repeat about 21 days after pasireotide initiation, per labeling for coadministration with QT-prolonging agents.
- Check and correct potassium and magnesium; pasireotide can cause and , which add to risk.
- Review other QT-prolonging drugs and risk factors (bradycardia, congenital long QT, cardiac disease).
- Consider the dose of iloperidone and the need for alternatives if becomes significantly prolonged.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Pasireotide Injection and Iloperidone Interact
The likely mechanism
How to Manage the Pasireotide Injection and Iloperidone Interaction
Your care team can usually manage this with careful planning and monitoring.
- An is typically done before pasireotide is started and again about 21 days after starting.
- Doses may need to be adjusted and individualized by your care team based on your results.
- Keep taking both medicines as prescribed unless your prescriber tells you otherwise.
- Give your pharmacist and doctor a full list of your medicines, including any other heart rhythm or drugs.
- Report fainting, severe dizziness, or a pounding or irregular heartbeat promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Pasireotide Injection or Iloperidone need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Pasireotide Injection and Iloperidone: Common Questions
How serious is the Pasireotide Injection and Iloperidone interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Pasireotide Injection and Iloperidone interaction managed?
Your care team can usually manage this with careful planning and monitoring. An is typically done before pasireotide is started and again about 21 days after starting. Doses may need to be adjusted and individualized by your care team based on your results. Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Give your pharmacist and doctor a full list of your m… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Pasireotide Injection and Iloperidone Interaction
Ask in your own words about taking Pasireotide Injection and Iloperidone together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: SIGNIFOR(R) LAR intramuscular injection suspension, pasireotide intramuscular injection suspension. Novartis Pharmaceuticals Corporation (per FDA), East Hanover, NJ, 2014.
Other Serious Interactions of Pasireotide Injection and Iloperidone
Also serious with Iloperidone
- Ketoconazole TopicalContraindicated
- Metoclopramide InjectionContraindicated
- Metoclopramide Nasal SprayContraindicated
- DronedaroneContraindicated
Also serious with Pasireotide Injection
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.